
November 3, 2017 - By Adrian Erickson
Envestnet Asset Management Inc increased its stake in Novo (NVO) by 25.82% based on its latest 2017Q2 regulatory filing with the SEC. Envestnet Asset Management Inc bought 239,690 shares as the company’s stock rose 15.20% with the market. The institutional investor held 1.17M shares of the major pharmaceuticals company at the end of 2017Q2, valued at $50.09M, up from 928,271 at the end of the previous reported quarter. Envestnet Asset Management Inc who had been investing in Novo for a number of months, seems to be bullish on the $97.72 billion market cap company. The stock rose 0.52% or $0.26 reaching $49.89 per share. About 2.60M shares traded or 18.18% up from the average. Novo Nordisk A S (ADR) (NYSE:NVO) has declined 23.93% since November 3, 2016 and is downtrending. It has underperformed by 40.63% the S&P500.Envestnet Asset Management Inc, which manages about $60.39 billion and $36.17 billion US Long portfolio, decreased its stake in Ishares Tr (IJJ) by 27,374 shares to 233,686 shares, valued at $34.71M in 2017Q2, according to the filing. It also reduced its holding in Target Corp (NYSE:TGT) by 76,238 shares in the quarter, leaving it with 52,190 shares, and cut its stake in Ingersoll (NYSE:IR). More notable recent Novo Nordisk A S (ADR) (NYSE:NVO) news were published by: Nasdaq.com which released: “Novo Nordisk (NVO) Tops Q3 Earnings Estimates, Lags Sales” on November 01, 2017, also Globenewswire.com with their article: “Novo Nordisk A/S – Share repurchase programme” published on October 31, 2017, Fool.com published: “Novo Nordisk results: The raw numbers” on August 14, 2017. More interesting news about Novo Nordisk A S (ADR) (NYSE:NVO) were released by: Fool.com and their article: “Here’s Why Novo Nordisk A/S Gained 12% in August” published on September 06, 2017 as well as Fool.com‘s news article titled: “Why Novo Nordisk A/S (ADR) Jumped 10.6% In May” with publication date: June 10, 2017.Among 13 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Novo Nordisk (ADR) had 15 analyst reports since August 28, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Monday, February 8 by UBS. The firm earned “Neutral” rating on Wednesday, September 6 by Bank of America. The rating was initiated by Leerink Swann with “Market Perform” on Friday, August 28. The rating was upgraded by HSBC to “Hold” on Wednesday, August 31. The firm earned “Buy” rating on Tuesday, December 6 by UBS. The firm earned “Neutral” rating on Friday, September 23 by Piper Jaffray. The firm has “Hold” rating given on Monday, October 31 by DNB Markets. The stock of Novo Nordisk A S (ADR) (NYSE:NVO) earned “Outperform” rating by BNP Paribas on Tuesday, September 13. The stock has “Equal-Weight” rating by Morgan Stanley on Thursday, September 1. The rating was upgraded by Goldman Sachs on Monday, February 15 to “Conviction Buy”.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading